| |
|
|
| Name: |
BB BIOTECH AG |
| City: |
SCHAFFHAUSEN |
| State: |
V8 |
| Zip: |
CH8300 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
35 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
IONS |
Ionis Pharmaceuticals Inc |
1 |
- |
$41.84 |
$627,038,000 |
7,725,000 |
15.76% |
154,481,000 |
-1,016,334 |
6.199 |
Drug Manufacturers - ... |
|
|
INCY |
Incyte Corp |
2 |
- |
$51.18 |
$311,356,000 |
3,620,000 |
7.83% |
69,185,000 |
-188,322 |
1.715 |
Biotechnology |
|
|
NBIX |
Neurocrine Biosciences Inc |
3 |
- |
$137.76 |
$296,614,000 |
3,366,786 |
7.46% |
57,884,000 |
23,696 |
3.721 |
Biotechnology |
|
|
VRTX |
Vertex Pharmaceuticals Inc |
4 |
- |
$397.70 |
$239,135,000 |
1,300,000 |
6.01% |
12,039,000 |
-70,445 |
0.514 |
Drug Manufacturers - ... |
|
|
SAGE |
Sage Therapeutics, Inc. |
5 |
- |
$0.00 |
$218,730,000 |
1,375,229 |
5.5% |
86,997,000 |
0 |
2.933 |
N/A |
|
|
CELG |
Celgene Corp |
6 |
- |
$108.24 |
$207,548,000 |
2,200,000 |
5.22% |
59,893,000 |
-103,875 |
0.28 |
Drug Manufacturers - ... |
|
|
AGIO |
Agios Pharmaceuticals Inc |
7 |
- |
$31.67 |
$200,845,000 |
2,978,134 |
5.05% |
68,134,000 |
100,000 |
5.169 |
N/A |
|
|
ALXN |
Alexion Pharmaceuticals Inc |
8 |
- |
$182.50 |
$177,684,000 |
1,314,428 |
4.47% |
49,711,000 |
0 |
0.589 |
Drug Manufacturers - ... |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
9 |
- |
$143.71 |
$152,425,000 |
1,631,089 |
3.83% |
37,855,000 |
59,700 |
1.766 |
Biotechnology |
|
|
ESPR |
Esperion Therapeutics, Inc. |
10 |
- |
$1.99 |
$141,447,000 |
3,522,964 |
3.56% |
-14,629,000 |
130,000 |
12.966 |
Biotechnology |
|
|
RDUS |
Radius Health Inc. |
11 |
- |
$10.08 |
$135,227,000 |
6,781,685 |
3.4% |
24,575,000 |
71,409 |
14.892 |
N/A |
|
|
HALO |
Halozyme Therapeutics Inc |
12 |
- |
$38.46 |
$133,998,000 |
8,322,860 |
3.37% |
12,235,000 |
0 |
5.849 |
Biotechnology |
|
|
ARGX |
Argenx Se |
13 |
- |
$368.60 |
$112,948,000 |
904,739 |
2.84% |
27,951,000 |
20,000 |
2.788 |
N/A |
|
|
MRNA |
Moderna, Inc. |
14 |
- |
$0.00 |
$97,389,000 |
4,785,681 |
2.45% |
24,312,000 |
0 |
1.455 |
N/A |
|
|
MYOV |
Myovant Sciences Ltd. |
15 |
- |
$26.98 |
$85,881,000 |
3,597,882 |
2.16% |
26,840,000 |
0 |
5.913 |
N/A |
|
|
ICPT |
Intercept Inc |
16 |
- |
$19.00 |
$77,964,000 |
696,976 |
1.96% |
19,937,000 |
121,257 |
2.777 |
Biotechnology |
|
|
GILD |
Gilead Sciences Inc |
17 |
- |
$65.27 |
$74,255,000 |
1,142,204 |
1.87% |
-9,074,000 |
-190,000 |
0.087 |
Biotechnology |
|
|
NKTR |
Nektar Therapeutics |
18 |
- |
$1.32 |
$67,895,000 |
2,020,676 |
1.71% |
22,502,000 |
639,701 |
1.179 |
Drug Delivery |
|
|
EXEL |
Exelixis Inc |
19 |
- |
$23.53 |
$67,473,000 |
2,835,000 |
1.7% |
11,709,000 |
0 |
0.959 |
Research Services |
|
|
AKCA |
Akcea Therapeutics Inc |
20 |
- |
$18.14 |
$67,358,000 |
2,377,638 |
1.69% |
-4,570,000 |
-8,833 |
3.573 |
N/A |
|
|
MGNX |
Macrogenics Inc |
22 |
- |
$14.37 |
$61,132,000 |
3,400,000 |
1.54% |
19,434,000 |
116,728 |
5.532 |
Biotechnology |
|
|
WVE |
Wave Life Sciences Ltd. |
23 |
- |
$4.74 |
$56,915,000 |
1,465,002 |
1.43% |
-4,674,000 |
0 |
5.276 |
N/A |
|
|
VYGR |
Voyager Therapeutics, Inc. |
24 |
- |
$7.42 |
$54,852,000 |
2,865,841 |
1.38% |
27,913,000 |
0 |
8.867 |
N/A |
|
|
BOLD |
Audentes Therapeutics, Inc. |
25 |
- |
$59.97 |
$53,442,000 |
1,369,604 |
1.34% |
37,038,000 |
600,200 |
3.208 |
N/A |
|
|
ALDR |
Alder Biopharmaceuticals Inc |
26 |
- |
$18.88 |
$37,756,000 |
2,766,008 |
0.95% |
9,404,000 |
0 |
4.048 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
27 |
New |
$53.73 |
$28,950,000 |
810,462 |
0.73% |
28,950,000 |
810,462 |
2.007 |
N/A |
|
|
SRRK |
Scholar Rock Holding Corp |
28 |
- |
$13.96 |
$27,750,000 |
1,476,839 |
0.7% |
-1,651,000 |
196,861 |
5.851 |
N/A |
|
|
ITCI |
Intra Cellular Therapies Inc |
29 |
- |
$72.13 |
$26,796,000 |
2,200,000 |
0.67% |
1,738,000 |
0 |
5.066 |
N/A |
|
|
SGMO |
Sangamo Biosciences Inc |
30 |
- |
$0.52 |
$25,281,000 |
2,650,000 |
0.64% |
9,783,000 |
1,300,000 |
1.88 |
Biotechnology |
|
|
KZR |
Kezar Life Sciences, Inc. |
31 |
- |
$0.79 |
$21,652,000 |
1,220,503 |
0.54% |
2,337,000 |
402,071 |
6.4 |
N/A |
|
|
GTHX |
G1 Therapeutics Inc |
32 |
- |
$3.86 |
$11,154,000 |
671,925 |
0.28% |
-1,713,000 |
0 |
2.368 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
33 |
- |
$0.00 |
$6,082,000 |
2,295,272 |
0.15% |
688,000 |
0 |
8.292 |
N/A |
|
|
NVAX |
Novavax Inc |
34 |
- |
$0.36 |
$4,589,000 |
8,330,000 |
0.12% |
-10,738,000 |
0 |
35.492 |
Biotechnology |
|
|
FIXX |
Homology Medicines Inc |
35 |
New |
$0.93 |
$2,533,000 |
91,336 |
0.06% |
2,533,000 |
91,336 |
0.246 |
N/A |
|
|
REGN |
Regeneron Pharmaceuticals Inc |
36 |
Closed |
$890.68 |
$0 |
0 |
0% |
-25,456,000 |
-68,156 |
0 |
Biotechnology |
|
